(Halo-Benzo Carbonyl)Heterocyclo Fused Phenyl p38 Kinase Inhibiting Agents

Details for Australian Patent Application No. 2002246677 (hide)

Owner Merck & Co., Inc.

Inventors Ruzek, Rowena, D; Natarajan, Swaminathan Ravi; Kallashi, Florida; Doherty, James, B.; Rupprecht, Kathleen, M.; Chen, Meng-Hsin; Sinclair, Peter J.; Hong, Xingfang; Goulet, Joung, L.; Liu, Luping; Miao, Shouwu; Wisnoski, David, D.; Hunt, Julianne, A.; Bao, Jianming; Stelmach, John, E.

Agent Spruson & Ferguson

Pub. Number AU-B-2002246677

PCT Pub. Number WO2002/058695

Priority 60/256,822 20.12.00 US

Filing date 14 December 2001

Wipo publication date 6 August 2002

Acceptance publication date 16 November 2006

International Classifications

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/47 (2006.01) - Quinolines

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/50 (2006.01) - Pyridazines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 19/02 (2006.01) Drugs for skeletal disorders

C07D 239/72 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/00 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/00 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/00 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/00 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/00 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-B-2002246677

22 July 2004 Amendment Made

  The nature of the amendment is: Add the co-inventors Sinclair, Peter J. and Kallashi, Florida

16 November 2006 Application Accepted

  Published as AU-B-2002246677

15 March 2007 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002246678

2002246676-METHODS FOR DETERMINING ORGANISMS NOT REQUIRING THE SEPARATION OF FIXATIVE OR EXCESS PROBE